Roivant Sciences Ltd. (NASDAQ:ROIV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 06, 2026. The Healthcare company reported Q0…
Roivant Sciences Ltd. (NASDAQ:ROIV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 06, 2026.
The Healthcare company reported Q0 revenue of .
Roivant Sciences Ltd.'s stock currently trades at $25.82 with a market capitalization of $14.8B.
Current market data
NASDAQ · ROIV
$39.50
Up: +$0.59 · +1.49%
Live quote updated
Keep reading
earnings ·
sec_filing ·
institutional ·
sec_filing ·
